| Literature DB >> 31249337 |
W Souza1,2,3, S G Piperni3,4, P Laviola1,3,5, A L Rossi4, Maria Isabel D Rossi6, Bráulio S Archanjo7, P E Leite1,2,8, M H Fernandes9,10, L A Rocha3,11, J M Granjeiro1,2,3,12, A R Ribeiro13,14,15.
Abstract
Titanium (Ti) and its alloys are widely used in dental implants and hip-prostheses due to their excellent biocompatibility. Growing evidence support that surface degradation due to corrosion and wear processes, contribute to implant failure, since the release of metallic ions and wear particles generate local tissue reactions (peri-implant inflammatory reactions). The generated ions and wear debris (particles at the micron and nanoscale) stay, in a first moment, at the interface implant-bone. However, depending on their size, they can enter blood circulation possibly contributing to systemic reactions and toxicities. Most of the nanotoxicological studies with titanium dioxide nanoparticles (TiO2 NPs) use conventional two-dimensional cell culture monolayers to explore macrophage and monocyte activation, where limited information regarding bone cells is available. Recently three-dimensional models have been gaining prominence since they present a greater anatomical and physiological relevance. Taking this into consideration, in this work we developed a human osteoblast-like spheroid model, which closely mimics bone cell-cell interactions, providing a more realistic scenario for nanotoxicological studies. The treatment of spheroids with different concentrations of TiO2 NPs during 72 h did not change their viability significantly. Though, higher concentrations of TiO2 NPs influenced osteoblast cell cycle without interfering in their ability to differentiate and mineralize. For higher concentration of TiO2 NPs, collagen deposition and pro-inflammatory cytokine, chemokine and growth factor secretion (involved in osteolysis and bone homeostasis) increased. These results raise the possible use of this model in nanotoxicological studies of osseointegrated devices and demonstrate a possible therapeutic potential of this TiO2 NPs to prevent or reverse bone resorption.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31249337 PMCID: PMC6597791 DOI: 10.1038/s41598-019-45797-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Physicochemical characterization of TiO2 nanoparticles: (A) Transmission electron micrograph showing the primary size of TiO2 NPs and their agglomeration due to their high reactivity. (B) Crystalline phase identification of anatase by electron diffraction obtained in TEM. (C) Average diameter and polydispersity index (PDI) of TiO2 NPs after dispersion in water (0 h, control), 24 h after stabilization and incubated with medium culture (TiO2 NPs in BSA DMEM 10% FBS). TEM micrographs of TiO2 NPs in distilled water and in medium culture are shown demonstrating an alteration in NPs morphology. Data represent mean ± standard deviation (SD), n = 30 in each condition. #P < 0.05 vs control and *P < 0.05 vs control.
Figure 2Establishment and characterization of human osteoblast spheroids: (A) Schematic representation of spheroids formation after aggregation and compaction of cell suspension cultured in nonadherent conditions (B) phase contrast images obtained by optical microscopy demonstrating the growth of spheroids produced with different numbers of cells (10000, 20000, 30000 and 50000 cells). (C) Spheroid diameter and volume is plotted against the different number of plated cells from three independent experiments (n = 10). Data are shown as mean ± SD. Spheroid diameter and volume was calculated based on phase contrast image analysis by area determination using image J software. A p-value < 0.05 is marked as statistically significant (***).
Figure 3Spheroids characterization: (A) Cell viability of spheroids produced with different cell numbers measured by Dead Cell Apoptosis Kit in flow cytometry. Bars are shown as mean ± SD, calculated from a group of 12 spheroids for each condition. *P < 0.05 vs control. (B) Morphology of the spheroids produced with 10000 cells obtained by scanning electron microscopy where high magnification images demonstrate cell-cell interactions (B1). (C) Confocal microscopy of a live spheroid stained in red with ethidium-positive (dead cells) and in green with calcein-positive (live cells), merged image demonstrating the presence of live and dead cells. The fluorescence intensity profiles for both channels show the different distribution of live and dead cells in the spheroid structure.
Figure 4Spheroid size, proliferation, viability and cell cycle analysis after nanoparticles exposure (5 and 100 µg/ml of TiO2 NPs for 72 hours): (A) Spheroid diameter and volume of 10,000 cells spheroids upon NPs exposure was calculated based on phase contrast image analysis by area determination using image J software. Data are shown as mean ± SD of three independent experiments (n = 10). (B) spheroid proliferation during formation and NPs exposure. (C) Annexin V/PI assay captures the different cell death profiles in the spheroids exposed to different concentrations of TiO2 NPs. (D) cell cycle analysis showing percentages of Go-G1 phase, S and G2/M phase of spheroids exposed to NPs. Bar represents the mean ± SD performed with 4 spheroids in each condition and the analyses were performed in triplicate. * and **P < 0.05 vs control.
Figure 5Spheroid organization and TiO2 NPs internalization: (A1) SEM micrograph of spheroids in the control condition (without NPs); (A2) with 5 and (A3) 100 µg/ml TiO2 NPs exposure for 72 hours. (B1–B6) Internalization and distribution of TiO2 NPs in spheroids exposed to 100 µg/ml NPs; (B1) Scanning TEM (STEM) micrograph of the interior of the spheroids. (B2) Schematic illustration of the penetration behavior of TiO2 NPs, (B3) STEM micrograph of the outer layers of the spheroid showing TiO2 NPs in the space between cells, (B4) and in membrane-vesicle, (B5) high magnification of the membrane vesicle, (B6) STEM/EDS map of Ti-K X-ray line confirming the presence of TiO2 NPs. Images are representative of four independent analysis.
Figure 6Spheroid differentiation, mineralization and matrix organization after TiO2 NPs exposure (5 and 100 µg/ml of TiO2 NPs during 72 hours): cross sections of paraffin-embedded spheroids stained with: (A) alkaline phosphatase for differentiation, (B) Alizarin Red S to visualize calcium deposition, (C) and Masson’s trichrome and (D) aniline blue staining for collagen. Images shown are representative of three independent experiments with triplicates. The arrows indicate the presence of TiO2 NPs. (E,F) TEM image of an ultrathin section of an osteoblast spheroid where inset delineated by a dotted line in E is magnified in F and demonstrate the presence of collagen fibrils. (G) Quantification of collagen deposition was performed by Blue pixel analysis and quantification in aniline blue sections using Image J software. Data show mean ± SD of three independent experiments in triplicates for each condition. *P < 0.05 vs control.
Figure 7Secreted inflammatory mediators by osteoblasts upon TiO2 NPs exposure (5 and 100 µg/ml of TiO2 NPs during 72 hours): After TiO2 NPs treatment, the supernatant was collected and the secreted inflammatory mediator’s analyzed. Data show mean ± SD of three independent experiments. *P < 0.05 vs control.